Immunomedics (IMMU) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Immunomedics Reports First Quarter 2020 Results and Provides Corporate Update
May 6, 2020 4:00 PM EDTTrodelvy received accelerated approval from FDA for third-line metastatic triple-negative breast cancer
First patient treated with Trodelvy following successful commercial launch
ASCENT study stopped early due to compelling evidence of efficacy across multiple endpoints, topline results around mid-2020
MORRIS PLAINS, N.J., May 06, 2020 (GLOBE NEWSWIRE) -- Immunomedics,... More
